Malcolm Mascarenhas

<i>In vitro</i> antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00

Kalpana Joshi, Maggie J. Rathos, Rajendra Joshi et al. · Molecular Cancer Therapeutics · 2007 · 121 citations · Full text

Chemoprevention Strategy, Retinoblastoma Protein, Cell Cycle +16

DMSO–POCl3: a reagent for methylthiolation of imidazo[1,2-a]pyridines and other imidazo-fused heterocycles

Shashikant Patil, Sarang Kulkarni, Malcolm Mascarenhas et al. · Tetrahedron · 2013 · 67 citations

Engineering, Heterocyclic, Other Imidazo-fused Heterocycles +5

Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents

Nitin P. Lad, Yogesh Manohar, Malcolm Mascarenhas et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 44 citations

Medicinal Chemistry, Antimicrobial Drug Discovery, Derivatives +14

Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines

Nitin P. Lad, Sarang Kulkarni, Rajiv Sharma et al. · European Journal of Medicinal Chemistry · 2016 · 28 citations

Medicinal Chemistry, Cyclic Sulfonamides, Therapeutic Potential +10

A new synthesis of sultams from amino alcohols

Nitin P. Lad, Rajiv Sharma, Víctor E. Márquez et al. · Tetrahedron Letters · 2013 · 19 citations

Medicinal Chemistry, Bioorganic Chemistry, Natural Sciences +5